205 related articles for article (PubMed ID: 27438608)
21. [Laparoscopic pelvic lymphadenectomy in patients with cancer of the bladder and prostate].
Dudiev SM
Urologiia; 2000; (5):52-4. PubMed ID: 11392228
[No Abstract] [Full Text] [Related]
22. A subset of nondescript axillary lymph node inclusions have the immunophenotype of endosalpingiosis.
Carney E; Cimino-Mathews A; Argani C; Kronz J; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1612-7. PubMed ID: 24921637
[TBL] [Abstract][Full Text] [Related]
23. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
24. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer.
Barth PJ; Gerharz EW; Ramaswamy A; Riedmiller H
Pathol Res Pract; 1999; 195(9):633-6. PubMed ID: 10507083
[TBL] [Abstract][Full Text] [Related]
25. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
26. Benign salivary gland tissue inclusion in a pulmonary hilar lymph node from a patient with invasive well-differentiated adenocarcinoma of the lung: a potential misinterpretation for the staging of carcinoma.
Lewis AL; Truong LD; Cagle P; Zhai QJ
Int J Surg Pathol; 2011 Jun; 19(3):382-5. PubMed ID: 21087984
[TBL] [Abstract][Full Text] [Related]
27. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
28. Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
Abdollah F; Sun M; Thuret R; Budäus L; Jeldres C; Graefen M; Briganti A; Perrotte P; Rigatti P; Montorsi F; Karakiewicz PI
Eur Urol; 2010 Dec; 58(6):882-92. PubMed ID: 20932637
[TBL] [Abstract][Full Text] [Related]
29. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
Heidenreich A; Pfister D; Thüer D; Brehmer B
BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
[TBL] [Abstract][Full Text] [Related]
30. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
31. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
32. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
33. The role of periprostatic and periseminal vesicle lymph node metastasis in the staging and prognosis of prostate cancer.
Subik MK; Yao JL; di Sant'Agnese PA; Miyamoto H
Histopathology; 2012 May; 60(6):1009-10. PubMed ID: 22372986
[No Abstract] [Full Text] [Related]
34. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract][Full Text] [Related]
35. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
[TBL] [Abstract][Full Text] [Related]
37. [Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions].
Weckermann D; Hamm M; Dorn R; Wagner T; Wawroschek F; Harzmann R
Urologe A; 2006 Jun; 45(6):723-7. PubMed ID: 16586052
[TBL] [Abstract][Full Text] [Related]
38. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
[TBL] [Abstract][Full Text] [Related]
39. Frequency and histogenesis of pelvic retroperitoneal lymph node inclusions of the female genital tract. An immunohistochemical study of 34 cases.
Horn LC; Bilek K
Pathol Res Pract; 1995 Oct; 191(10):991-6. PubMed ID: 8838366
[TBL] [Abstract][Full Text] [Related]
40. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.
Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A
Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]